查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565674

暴露前預防 (PrEP) 市場，按產品類型、按使用類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Pre-Exposure Prophylaxis (PrEP) Market, By Product Type, By Usage Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年暴露前預防（PrEP）市場規模為49.8043億美元，2024年至2032年複合年成長率為12.30%。

暴露前預防 (PrEP) 市場-市場動態

提高對 PrEP 有效性和可用性的認知和教育。

對 PrEP 有效性和可用性的認知和教育的提高極大地推動了 PrEP 市場的發展。隨著越來越多的人了解 PrEP 如何預防愛滋病毒，對該藥物的需求不斷增加。美國疾病管制與預防中心 (CDC) 報告稱，宣傳活動的加強導致高風險族群中 PrEP 的使用大幅增加。

美國疾病管制與預防中心 (CDC) 報告稱，截至 2021 年，近 60% 的 HIV 高風險族群了解 PrEP。 CDC 也指出，從 2018 年到 2021 年，PrEP 處方數量增加了 25%，反映出人們對這種預防性治療的認知和採用不斷增強。認知度和利用率的提高是 PrEP 市場不斷擴大的關鍵驅動力。

暴露前預防 (PrEP) 市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 12.30% 左右的複合年成長率成長

根據產品類型細分，預計品牌 PrEP 將在 2023 年顯示最大的市場佔有率

根據使用類型細分，每日口服 PrEP 是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

暴露前預防 (PrEP) 市場區隔分析：

全球暴露前預防 (PrEP) 市場根據產品類型、使用類型、最終用戶和地區進行細分。

依產品類型，市場分為兩類：通用 PrEP、品牌 PrEP。在暴露前預防 (PrEP) 市場中，品牌 PrEP 細分市場目前佔據主導地位。這主要歸功於 Truvada 和 Descovy 等品牌產品的強大市場影響力和廣泛推廣。品牌 PrEP 受益於既定的品牌知名度、全面的臨床支援和廣泛的分銷網路。由於其經過驗證的功效和安全性，它們也經常獲得醫療保健提供者的優先推薦。相較之下，通用 PrEP 雖然可用性有所增加，但由於品牌認知度較低且可能不太全面的支持，在獲得市場佔有率方面仍面臨挑戰。

根據每日口服 PrEP 的使用類型，市場分為兩類。長效注射劑 在暴露前預防 (PrEP) 市場中，每日口服 PrEP 市場目前佔據主導地位。這種主導地位源於每日口服 PrEP 的長期使用和臨床驗證，例如 Truvada 和 Descovy，它們在功效和安全性方面擁有良好的記錄。每日口服 PrEP 已被醫療保健提供者廣泛使用和接受，為其帶來了巨大的市場佔有率。長效注射劑正在興起，但由於市場進入較新且長期資料點較少，尚未達到相同水平的市場滲透率。

暴露前預防 (PrEP) 市場 - 地理洞察

暴露前預防 (PrEP) 市場最大的地區是北美，尤其是美國。該地區領先的原因在於其先進的醫療基礎設施、對愛滋病毒預防的高度認知以及公共衛生舉措的大力支持。美國也受惠於 PrEP 藥物研發的大量投資。透過各種醫療保健計劃和保險範圍提供 PrEP 進一步促進了其採用。北美市場的主導地位得到了強力的監管框架和積極推廣 PrEP 使用的計劃團體的支持。

暴露前預防 (PrEP) 市場-競爭格局：

暴露前預防 (PrEP) 市場競爭激烈，幾個主要參與者佔據主導地位。吉利德科學公司 (Gilead Sciences, Inc.) 憑藉其 PrEP 產品 Truvada 及其新配方 Descovy 處於領先地位。 ViiV Healthcare 緊隨其後推出了 Apretude，這是一種長效注射 PrEP 選項。百時美施貴寶和楊森製藥公司也很重要，它們正在進行研究和潛在的 PrEP 開發。默克公司和艾伯維公司透過其 HIV 研究和新興的 PrEP 解決方案做出貢獻。羅氏和輝瑞公司參與愛滋病毒治療，影響 PrEP 市場。 Sage Therapeutics 和 Moderna, Inc. 是探索新預防方法的創新企業。 Mylan NV、Hikma Pharmaceuticals、Cipla Limited 和 Aurobindo Pharma 提供通用 PrEP 選項，擴大了可近性和可負擔性。這種競爭格局的特點是不斷創新和發展，旨在改善愛滋病毒的預防和治療結果。

最新進展：

2024 年 9 月，隨著第三階段的另一場勝利，吉利德正競相在 2025 年推出長效 PrEP 藥物。

2023年4月，默克公司（MRK.N）表示將以約108億美元收購Prometheus Biosciences Inc.（RXDX.O）。此次收購將使默克擴大在免疫學領域的立足點，並獲得治療潰瘍性結腸炎和克隆氏症的潛在實驗性治療方法。

目錄

第 1 章：暴露前預防 (PrEP) 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的暴露前預防 (PrEP) 市場片段
    • 按使用類型分類的暴露前預防 (PrEP) 市場片段
    • 最終使用者的暴露前預防 (PrEP) 市場片段
    • 按國家/地區分類的暴露前預防 (PrEP) 市場片段
    • 按地區分類的暴露前預防 (PrEP) 市場片段
  • 競爭洞察

第 3 章：暴露前預防 (PrEP) 主要市場趨勢

  • 暴露前預防 (PrEP) 市場促進因素
    • 市場促進因素的影響分析
  • 暴露前預防 (PrEP) 市場限制
    • 市場限制影響分析
  • 暴露前預防 (PrEP) 市場機會
  • 暴露前預防 (PrEP) 市場未來趨勢

第 4 章：暴露前預防 (PrEP) 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：暴露前預防 (PrEP) 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：暴露前預防 (PrEP) 市場格局

  • 2023 年暴露前預防 (PrEP) 市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：暴露前預防 (PrEP) 市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 通用 PrEP
    • 品牌 PrEP

第 8 章：暴露前預防 (PrEP) 市場 - 依使用類型

  • 概述
    • 按使用類型分類的細分市場佔有率分析
    • 每日口服 PrEP
    • 長效注射劑

第 9 章：暴露前預防 (PrEP) 市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 社區健康服務中心
    • 專門的愛滋病毒診所

第 10 章：暴露前預防 (PrEP) 市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美暴露前預防 (PrEP) 主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按使用類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲暴露前預防 (PrEP) 主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按使用類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區暴露前預防 (PrEP) 主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模和預測（按使用類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲暴露前預防 (PrEP) 主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按使用類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲暴露前預防 (PrEP) 主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模和預測（按使用類型）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 暴露前預防 (PrEP) 產業

  • 競爭儀表板
  • 公司簡介
    • Gilead Sciences, Inc.
    • ViiV Healthcare
    • Bristol-Myers Squibb
    • Janssen Pharmaceuticals
    • Merck & Co., Inc.
    • AbbVie Inc.
    • Roche
    • Pfizer Inc.
    • Sage Therapeutics
    • Moderna, Inc.
    • Mylan NV
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Aurobindo Pharma

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3845

REPORT HIGHLIGHT

Pre-Exposure Prophylaxis (PrEP) Market size was valued at USD 4,980.43 Million in 2023, expanding at a CAGR of 12.30% from 2024 to 2032.

Pre-exposure prophylaxis (PrEP) is a preventive treatment for high-risk individuals to reduce HIV infection. It involves taking a daily pill containing antiretroviral drugs. The PrEP market includes developing, manufacturing, and distributing these medications. This market has expanded due to increased HIV prevention awareness and access. Key players include pharmaceutical companies and healthcare providers. Ongoing research aims to improve PrEP options and explore new formulations.

Pre-Exposure Prophylaxis (PrEP) Market- Market Dynamics

Increased awareness and education about PrEP's effectiveness and availability.

Increased awareness and education about PrEP's effectiveness and availability significantly drive the PrEP market. As more people understand how PrEP can prevent HIV, demand for the drug rises. the Centers for Disease Control and Prevention (CDC) reported that increased awareness campaigns led to a substantial rise in PrEP use among high-risk populations.

The U.S. Centers for Disease Control and Prevention (CDC) reported that as of 2021, nearly 60% of individuals at high risk of HIV were aware of PrEP. The CDC also noted a 25% increase in PrEP prescriptions from 2018 to 2021, reflecting this preventive treatment's growing awareness and adoption. This rise in awareness and utilization is a key driver for the expanding PrEP market.

Pre-Exposure Prophylaxis (PrEP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.30% over the forecast period (2024-2032)

Based on product type segmentation, branded PrEP was predicted to show maximum market share in the year 2023

Based on Usage Type segmentation, daily oral PrEP was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pre-Exposure Prophylaxis (PrEP) Market- Segmentation Analysis:

The Global Pre-Exposure Prophylaxis (PrEP) Market is segmented on the basis of Product Type, Usage Type, End User, and Region.

The market is divided into two categories based on product type Generic PrEP, Branded PrEP. In the Pre-Exposure Prophylaxis (PrEP) market, the branded PrEP segment is currently the most dominant. This is largely due to the strong market presence and extensive promotion of branded products like Truvada and Descovy. Branded PrEPs benefit from established brand recognition, comprehensive clinical support, and extensive distribution networks. They also often receive preferential recommendations from healthcare providers due to their proven efficacy and safety profiles. In contrast, generic PrEPs, while increasing in availability, still face challenges in gaining market share due to lower brand recognition and potentially less comprehensive support.

The market is divided into two categories based on the Usage Type Daily Oral PrEP. Long-Acting Injectables In the Pre-Exposure Prophylaxis (PrEP) market, the daily oral PrEP segment is currently the most dominant. This dominance stems from the long-standing use and clinical validation of daily oral PrEP, such as Truvada and Descovy, which have a well-established track record for efficacy and safety. Daily oral PrEP is widely available and accepted by healthcare providers, contributing to its significant market share. Long-acting injectables are emerging but have not yet achieved the same level of market penetration due to newer market entry and fewer long-term data points.

Pre-Exposure Prophylaxis (PrEP) Market- Geographical Insights

The largest region for the Pre-Exposure Prophylaxis (PrEP) market is North America, particularly the United States. This region leads due to its advanced healthcare infrastructure, high awareness of HIV prevention, and strong support from public health initiatives. The U.S. also benefits from significant investments in research and development for PrEP medications. The availability of PrEP through various healthcare programs and insurance coverage further boosts its adoption. North America's market dominance is supported by robust regulatory frameworks and active advocacy groups promoting PrEP usage.

Pre-Exposure Prophylaxis (PrEP) Market- Competitive Landscape:

The Pre-Exposure Prophylaxis (PrEP) market is highly competitive, with several major players dominating the landscape. Gilead Sciences, Inc.leads with its PrEP product, Truvada, and its newer formulation, Descovy. ViiV Healthcare follows with Apretude, a long-acting injectable PrEP option. Bristol-Myers Squibb and Janssen Pharmaceuticals are also significant, with ongoing research and potential PrEP developments. Merck & Co., Inc. and AbbVie Inc. contribute through their HIV research and emerging PrEP solutions. Roche and Pfizer Inc. are involved in HIV treatments, influencing the PrEP market. Sage Therapeutics and Moderna, Inc. are innovative players exploring new prevention methods. Mylan N.V., Hikma Pharmaceuticals, Cipla Limited, and Aurobindo Pharma provide generic PrEP options, expanding access and affordability. This competitive landscape is characterized by continuous innovation and development aimed at improving prevention and treatment outcomes for HIV.

Recent Developments:

In September 2024, with yet another phase 3 victory, Gilead is racing to introduce a long-acting PrEP medication in 2025.

In April 2023, Merck & Co. (MRK.N) said that it will acquire Prometheus Biosciences Inc. (RXDX.O) for approximately $10.8 billion. The acquisition will allow Merck to expand its foothold in immunology and acquire a potential experimental treatment for ulcerative colitis and Crohn's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences, Inc.
  • ViiV Healthcare
  • Bristol-Myers Squibb
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Roche
  • Pfizer Inc.
  • Sage Therapeutics
  • Moderna, Inc.
  • Mylan N.V.
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Aurobindo Pharma

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Generic PrEP
  • Branded PrEP

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Daily Oral PrEP
  • Long-Acting Injectables

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Community Health Centers
  • Specialized HIV Clinics

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pre-Exposure Prophylaxis (PrEP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Product Type
    • 2.1.2. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Usage Type
    • 2.1.3. Pre-Exposure Prophylaxis (PrEP) Market Snippet by End User
    • 2.1.4. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Country
    • 2.1.5. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Pre-Exposure Prophylaxis (PrEP) Key Market Trends

  • 3.1. Pre-Exposure Prophylaxis (PrEP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pre-Exposure Prophylaxis (PrEP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pre-Exposure Prophylaxis (PrEP) Market Opportunities
  • 3.4. Pre-Exposure Prophylaxis (PrEP) Market Future Trends

4. Pre-Exposure Prophylaxis (PrEP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pre-Exposure Prophylaxis (PrEP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pre-Exposure Prophylaxis (PrEP) Market Landscape

  • 6.1. Pre-Exposure Prophylaxis (PrEP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pre-Exposure Prophylaxis (PrEP) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Generic PrEP
    • 7.1.3. Branded PrEP

8. Pre-Exposure Prophylaxis (PrEP) Market - By Usage Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Usage Type, 2023 & 2032 (%)
    • 8.1.2. Daily Oral PrEP
    • 8.1.3. Long-Acting Injectables

9. Pre-Exposure Prophylaxis (PrEP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Community Health Centers
    • 9.1.4. Specialized HIV Clinics

10. Pre-Exposure Prophylaxis (PrEP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pre-Exposure Prophylaxis (PrEP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Gilead Sciences, Inc.
    • 11.2.2. ViiV Healthcare
    • 11.2.3. Bristol-Myers Squibb
    • 11.2.4. Janssen Pharmaceuticals
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. AbbVie Inc.
    • 11.2.7. Roche
    • 11.2.8. Pfizer Inc.
    • 11.2.9. Sage Therapeutics
    • 11.2.10. Moderna, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Hikma Pharmaceuticals
    • 11.2.13. Cipla Limited
    • 11.2.14. Aurobindo Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us